REGN vs STEM
Regeneron Pharmaceuticals Inc (REGN) versus Stem Inc (STEM) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Stem Inc (STEM) is a utilities - renewable company listed on US.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported STEM revenue for 2024-12-31 was $144.6M. Net income was -$854.0M. Revenue was down 68.7% from 2023-12-31 to 2024-12-31. STEM currently screens at market cap $82.1M.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. STEM currently screens at market cap $82.1M.
Not investment advice. Open the REGN and STEM stock pages for the full models.
Not investment advice.